11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess
about
Green tea and one of its constituents, Epigallocatechine-3-gallate, are potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1Appropriate function of 11beta-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esteraseMolecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabeticsThe molecular biology, biochemistry, and physiology of human steroidogenesis and its disordersCongenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guidelineAdrenal Diagnostics: An Endocrinologist's Perspective focused on HyperaldosteronismThe association of genetic variations with sensitivity of blood pressure to dietary salt: A narrative literature reviewThe N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membraneCurcumin as a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase 1: improving lipid profiles in high-fat-diet-treated ratsDHEA induces 11 -HSD2 by acting on CCAAT/enhancer-binding proteinsFamilial glucocorticoid receptor haploinsufficiency by non-sense mediated mRNA decay, adrenal hyperplasia and apparent mineralocorticoid excess.High-sodium intake aggravates myocardial injuries induced by aldosterone via oxidative stress in Sprague-Dawley rats.Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2.Fetal growth restriction alters transcription factor binding and epigenetic mechanisms of renal 11beta-hydroxysteroid dehydrogenase type 2 in a sex-specific manner.Consumption of green coffee reduces blood pressure and body composition by influencing 11β-HSD1 enzyme activity in healthy individuals: a pilot crossover study using green and black coffee.11Beta-hydroxysteroid-dehydrogenase isoforms: tissue distribution and implications for clinical medicine.High salt intake down-regulates colonic mineralocorticoid receptors, epithelial sodium channels and 11β-hydroxysteroid dehydrogenase type 2Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1.Licorice-associated reversible cerebral vasoconstriction with PRES.Ontogeny of adrenal steroid biosynthesis: why girls will be girls.High and low protein∶ carbohydrate dietary ratios during gestation alter maternal-fetal cortisol regulation in pigs.Why is management of patients with classical congenital adrenal hyperplasia more difficult at puberty?Role of mineralocorticoid receptor antagonists in cardiovascular disease.A pharmacological screening approach for discovery of neuroprotective compounds in ischemic strokeAdrenocortical carcinoma initially presenting with hypokalemia and hypertension mimicking hyperaldosteronism: a case report.Herbal Medicine Containing Licorice May Be Contraindicated for a Patient with an HSD11B2 MutationCortisol biosynthesis in the human ocular surface innate immune response.Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairmentsReduced cortisol metabolism during critical illnessHexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolismGlucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects.Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathyGuidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)Glucocorticoid metabolism in the human fetal lung: implications for lung development and the pulmonary surfactant system.Glucocorticoid "programming" and PTSD risk.A novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis.Mineralocorticoid Excess or Glucocorticoid Insufficiency: Renal and Metabolic Phenotypes in a Rat Hsd11b2 Knockout Model.Renal medullary 11 beta-hydroxysteroid dehydrogenase type 1 in Dahl salt-sensitive hypertension.Bimodal aldosterone distribution in low-renin hypertension
P2860
Q21089692-8E667537-FFD5-441C-8896-5BB0B1F1F531Q24293608-9D91B4BD-9982-4BFB-8278-A86DB6108497Q24539134-22A09734-09D8-41FF-BA2B-744344A5C2F4Q24564713-E35EB443-8123-4296-86D8-4F5D32C5A677Q24613957-683190A3-DB6F-499B-92E4-61C3D0664433Q24614223-58CEFA18-5885-4570-B72C-6CB781881709Q27006954-1850F860-83B2-4344-B659-CAF9DAD36B6EQ27025026-BAAFD553-A218-4F95-A2CE-2D0F5BE07577Q28144963-2309C297-DA52-4490-8C23-DE91D0561A86Q28488754-1473F538-89DF-4A19-BAF8-C9875972EF67Q28573234-8E1A3FFB-EAA5-438B-A611-BFC676B1708EQ33735950-BBF91777-7A10-4EB5-B223-5B9408C9743DQ33828715-E8BE86AD-6B45-4562-A9EA-1D913CDD3FD2Q33843488-2EF6CAD8-9F02-475A-9242-5B5B5702E536Q33995009-0A0FB928-DBA0-41C5-A201-EE755F7FA09BQ34009668-58458DB0-9FAD-4FA0-B733-CBE42EC75809Q34204005-55F1E118-E754-4F61-BC15-B68D52633E7CQ34302357-5A0019A2-91D9-4FBC-9F00-892885B8E38FQ34353804-E0C10F71-6A64-402E-9667-7C8F0B2EF55BQ34370042-8FA271C6-D46D-42D7-9E71-0FBA513F137CQ34498960-AD6A3B4B-AA3F-4898-B0BE-70B07B14AD1AQ34541106-FB41C111-816D-49FF-898D-195DEDB50BBCQ34580012-C8FBA6AA-8A82-493F-B16E-7836A76BDB32Q34817129-A5E28B8E-6A8C-4698-88EC-BF8C79E3C111Q34853494-5A7D384A-FA98-4862-8094-94ECEE28BF00Q35011124-68A5B535-2504-4E2B-9A81-979BCE053DD3Q35106732-54924F3B-9EDB-44DA-95EE-A11CBA4ABDEDQ35149219-3E379CB7-4015-43EE-A379-77A5C039ED05Q35300139-E49A41BA-4DC0-41C9-86CC-98A840AB280FQ35549611-F7A6E138-8F9F-4988-92DE-B837E3BE92DAQ35751847-844ABCF0-9409-4256-9597-390F05466F18Q36065521-A927FD62-A325-4A86-82B5-629E92CA4626Q36068308-116E0146-2CF8-4667-A173-9D14CADE4C74Q36265163-5E692ADC-25E1-42AD-9340-579554AF3116Q36272922-F01BD7F8-B6D1-4E55-A7BF-54E6BCF874DFQ36557730-4E35F5F9-8B4D-48CC-8279-A3B4FB03CDAFQ36562971-FBDE0185-8C9D-494A-B90E-1EA9C5E2E5BAQ36844144-257AB8D3-7FE2-4C9A-B488-24B1D60E13C4Q37018261-16AAD5B4-06C9-4052-BDB7-F80D2B5B59B2Q37089535-1B8B9B1C-62E4-4DCF-91B9-6F25097DD227
P2860
11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
11 beta-Hydroxysteroid dehydro ...... arent mineralocorticoid excess
@ast
11 beta-Hydroxysteroid dehydro ...... arent mineralocorticoid excess
@en
11 beta-Hydroxysteroid dehydro ...... arent mineralocorticoid excess
@nl
type
label
11 beta-Hydroxysteroid dehydro ...... arent mineralocorticoid excess
@ast
11 beta-Hydroxysteroid dehydro ...... arent mineralocorticoid excess
@en
11 beta-Hydroxysteroid dehydro ...... arent mineralocorticoid excess
@nl
prefLabel
11 beta-Hydroxysteroid dehydro ...... arent mineralocorticoid excess
@ast
11 beta-Hydroxysteroid dehydro ...... arent mineralocorticoid excess
@en
11 beta-Hydroxysteroid dehydro ...... arent mineralocorticoid excess
@nl
P2093
P356
P1433
P1476
11 beta-Hydroxysteroid dehydro ...... arent mineralocorticoid excess
@en
P2093
P304
P356
10.1210/ER.18.1.135
P407
P577
1997-02-01T00:00:00Z